Alzheimer's Matters Blog

2018 Year in Review

ADDF Impact

Top 5 Advances in 2018

In 2018 we have seen increased investments in Alzheimer's biomarkers and increased interest in prevention.

Ninth Annual Fall Symposium

ADDF Impact

Leading Scientists Share Exciting Research Developments at the ADDF Fall Symposium

At the ADDF's Ninth Annual Fall Symposium, Richard S. Isaacson, Michelle M. Mielke, and Mark A. Mintun discussed Alzheimer's biomarkers and prevention.

19th International Conference on Alzheimer's Drug Discovery

Developing Drugs

Two Decades of Research: The ADDF’s 19th International Conference on Alzheimer’s Drug Discovery

Researchers shared updates on their approaches to developing Alzheimer's treatments at our annual conference.

Marty and Jaclyn Reiswig

Supporter Stories

The Cure Needs You: Getting Involved in Clinical Trials

Marty Reiswig talks about the importance of participating in Alzheimer's clinical trials.

Developing Drugs

Top Five Highlights from AAIC 2018

The ADDF looks back at the 2018 Alzheimer's Association International Conference.

Wolf Blitzer and Dr. Ron Crystal

Developing Drugs

Gene Therapy, A New Frontier in Alzheimer’s

Dr. Ron Crystal and his team at Weill Cornell developed a gene therapy to replace APOE4 with APOE2, which would significantly lower Alzheimer's risk.